According to spokesperson Laurence Quesdeville, the “ever-increasing complexity of drugs and their administration, packaging has become as important as the product itself."
Quesdeville told in-PharmaTechnologist that: “We need to create products that make it easier for our customers to register their drugs," adding that "this does require increased resources and the scope of the new Rexam Healthcare will allow us to go one step further."
She added that the move creates “One point of entry, one global approach and one global set of standards make partnership with Rexam efficient and reliable. At the same time, the combined resources in R&D and industrialization boost innovation and project management efficiency.
"Each business will benefit from each other strength to globally create a strong customer-focused entity and simplify commercial approach for the benefit of our customers.
Global synergies
Quesdeville stressed that the Healthcare unit will allow the firm to strengthen its operations in one region with capabilities already held in another, citing the application of its US container and closure expertise to its European operations as a one potential area of synergy.
She also suggested that consolidation will help Rexam drive growth in emerging markets, such as Mexico and India, adding that a key focus of the unit is to provide the same levels of service and quality as it does in established markets like Europe and the US.
Quesdeville added that, in addition to its new facility in Bangalore, India, Rexam plans to further expand its operations in Asia.
In a press release, Marc Haemel who heads up the new healthcare unit reiterated the focus on providing quality contract packaging and development services to the industry.
He suggested that: “[By] merging these businesses, we are bringing together successful teams to create an even stronger global entity.”